130 related articles for article (PubMed ID: 12458334)
1. Evaluation of radiation carcinogenesis risk in vertebral hemangioma treated by radiotherapy.
Beyzadeoglu M; Dirican B; Oysul K; Surenkok S; Pak Y
Neoplasma; 2002; 49(5):338-41. PubMed ID: 12458334
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dose homogenization and radiation carcinogenesis risk in total body irradiation for bone marrow transplantation.
Oysul K; Dirican B; Beyzadeoglu M; Sürenkok S; Arpaci F; Pak Y
Neoplasma; 2003; 50(5):372-6. PubMed ID: 14628091
[TBL] [Abstract][Full Text] [Related]
3. Heel spur radiotherapy and radiation carcinogenesis risk estimation.
Surenkok S; Dirican B; Beyzadeoglu M; Oysul K
Radiat Med; 2006 Oct; 24(8):573-6. PubMed ID: 17041794
[TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy in vertebral hemangioma].
Heyd R; Strassmann G; Filipowicz I; Borowsky K; Martin T; Zamboglou N
Rontgenpraxis; 2001; 53(5):208-20. PubMed ID: 11341017
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of radiotherapy for vertebral hemangiomas.
Miszczyk L; Ficek K; Trela K; Spindel J
Neoplasma; 2001; 48(1):82-4. PubMed ID: 11327544
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy of painful vertebral hemangiomas: the single center retrospective analysis of 137 cases.
Miszczyk L; Tukiendorf A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e173-80. PubMed ID: 21640516
[TBL] [Abstract][Full Text] [Related]
9. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
10. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT.
Sharma SD; Upreti RR; Laskar S; Tambe CM; Deshpande DD; Shrivastava SK; Dinshaw KA
Radiother Oncol; 2008 Feb; 86(2):177-81. PubMed ID: 18082906
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.
Heyd R; Seegenschmiedt MH; Rades D; Winkler C; Eich HT; Bruns F; Gosheger G; Willich N; Micke O;
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):217-25. PubMed ID: 19699592
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic vertebral hemangioma: treatment with radiotherapy.
Aich RK; Deb AR; Banerjee A; Karim R; Gupta P
J Cancer Res Ther; 2010; 6(2):199-203. PubMed ID: 20622368
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk among Swedish hemangioma patients and possible consequences of radiation-induced genomic instability.
Eidemüller M; Holmberg E; Jacob P; Lundell M; Karlsson P
Mutat Res; 2009 Oct; 669(1-2):48-55. PubMed ID: 19416732
[TBL] [Abstract][Full Text] [Related]
14. Estimation of cancer risks from radiotherapy of benign diseases.
Trott KR; Kamprad F
Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
16. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
Tubiana M
Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
18. A small prospective study of chordomas treated with radiotherapy and razoxane.
Rhomberg W; Böhler FK; Novak H; Dertinger S; Breitfellner G
Strahlenther Onkol; 2003 Apr; 179(4):249-53. PubMed ID: 12707714
[TBL] [Abstract][Full Text] [Related]
19. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
20. Cancer mortality after radiotherapy for a skin hemangioma during childhood.
Dondon MG; de Vathaire F; Shamsaldin A; Doyon F; Diallo I; Ligot L; Paoletti C; Labbé M; Abbas M; Chavaudra J; Avril MF; Fragu P; Eschwège F
Radiother Oncol; 2004 Jul; 72(1):87-93. PubMed ID: 15236880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
